Toxicology and ecotoxicology of para-aminopropiophenone (PAPP) – a new predator control tool for stoats and feral cats in New Zealand by Eason, Charles et al.
177Eason et al.: PAPP toxicology and ecotoxicology
REVIEW ARTICLE
Toxicology and ecotoxicology of para-aminopropiophenone (PAPP) – a new predator 
control tool for stoats and feral cats in New Zealand
Charles T. Eason1,2 *, Aroha Miller2,5, Duncan B. MacMorran3 and Elaine C. Murphy2,4
1Cawthron Institute, Private Bag 2, Nelson, 7042, New Zealand
2Centre for Wildlife Management and Conservation, Lincoln University, PO Box 84, Lincoln, Canterbury, New Zealand
3Connovation Ltd, PO Box 58613, Manukau 2163, New Zealand
4Department of Conservation, Private Bag 4715, Christchurch 8140, New Zealand
5Current address: Department of Applied Biology, University of British Columbia, 2357 Main Mall, Vancouver BC, Canada
* Author for correspondence (Email: charles.eason@cawthron.org.nz)
Published online: 9 April 2014
Abstract: Para-aminopropiophenone (PAPP) paste was approved as a stoat control agent in New Zealand by 
the Environmental Protection Authority in August 2011 and for feral cat control in November 2011. PAPP 
was originally researched in Europe and the USA as treatment for cyanide and radiation poisoning. Over 
the last 10 years, our research has focused on several factors, including determining its toxicity to predators, 
field effectiveness for controlling stoats and feral cats, animal welfare profile, toxicology, ecotoxicology, and 
understanding and reducing non-target risks. PAPP has been developed specifically for the control of stoats and 
feral cats because of the special sensitivity displayed by these species. Its toxicity is mediated by the induction 
of methaemoglobinaemia (the ferric state of haemoglobin). Normally, methaemoglobin levels in the blood 
are below 1%. Levels of methaemoglobin in the blood above 70% are usually fatal, creating a lethal deficit of 
oxygen in cardiac muscle and the brain. In stoats and feral cats, death after a lethal dose usually occurs within 
2 h after eating bait, with clinical signs first appearing in 10 to 20 min for stoats and at around 35 min for cats. 
Animals become lethargic and sleepy before they die, hence PAPP is relatively humane. A simple antidote exists, 
namely methylene blue. Further, birds display a lack of toxicity to PAPP when compared with other vertebrate 
pesticides. A paste containing 40% PAPP has been developed for use in meat baits in New Zealand. A toxic 
dose for stoats and feral cats is achieved when pea-sized amounts of paste are delivered in 10–20 g meat baits. 
When meat baits containing PAPP are applied in bait stations in field settings, stoat and feral cat numbers can 
be rapidly reduced. However, there has been limited practical experience with PAPP to date, especially when 
compared with alternative tools such as traps or sodium monofluoroacetate (1080) baits. Additional practical 
experience should enable the effective use of PAPP as a tool to help protect native species from introduced 
predators. In the future, PAPP will be developed in long-life bait and in a resetting toxin delivery system.
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Introduction
Stoats (Mustela erminea) were shipped to New Zealand from 
Britain in the 1880s and released on farmland in the hope that 
they would control rabbit (Oryctolagus cuniculus) numbers. 
Unfortunately they soon spread throughout the country, 
including to places where there were no rabbits (King & 
Murphy 2005). Cats (Felis catus) came with the European 
explorers and settlers from 1769 onwards and well established 
feral populations were reported in the 19th century. Cats 
were also introduced to many offshore and outlying islands 
(Gillies & Fitzgerald 2005). Both stoats and feral cats have 
been implicated in the ongoing decline of native New Zealand 
threatened species and ongoing control will be required to avert 
further extinctions (Dowding & Murphy 2001).
Para-aminopropiophenone (PAPP) has been developed as 
a Vertebrate Toxic Agent (VTA) specifically for the control of 
stoats and feral cats because of the special sensitivity displayed 
by these species. It has the potential to play a major role in 
the protection of threatened species. It is a compound with the 
formula C9H11NO and a molecular weight of 149.19. Prior to 
the registration of PAPP for stoat and feral cat control, 1080 
was the only toxin registered in New Zealand for feral cat 
control, while trapping and secondary poisoning from using 
1080 or anticoagulant toxins for possum and rat control were 
the only means of controlling stoats. Trapping is often labour-
intensive and expensive (Brown 2003). In this context, the 
need for an effective humane poison for stoats and feral cats 
was identified (Murphy et al. 2005, 2007), and is consistent 
with aspirations for continued improvements in the welfare 
aspects of pest control technology (Littin et al. 2004). PAPP 
has been developed in New Zealand to address this aspiration 
and need for a new tool for the control of stoats and feral cats. 
Paste containing PAPP as the active ingredient was approved 
as a stoat control agent by the New Zealand Environmental 
Protection Authority (EPA) in August 2011 and for feral cat 
control in November 2011. PAPP paste applied to fresh meat 
baits in bait stations has been shown to be effective for the 
control of both stoats and feral cats (Shapiro et al. 2010; Dilks 
et al. 2011; Murphy et al. 2011).
PAPP was not originally intended to be a vertebrate 
pesticide. Early research in Europe and the USA focused on 
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the potential of PAPP as a treatment for cyanide gas poisoning 
in the context of protecting soldiers during conflict (Rose et al. 
1947; Bright & Marrs 1982). During 1960–80, i.e. the Cold 
War era, PAPP was further investigated as an antidote for 
human radiation poisoning (Oldfield et al. 1965).
Extensive research into PAPP has been conducted over 
more than 50 years, including in vitro and in vivo toxicology 
trials, metabolism studies, and experiments using human 
volunteers (Jandorf & Bodansky 1946; Rose et al. 1947; 
Oldfield et al. 1965; Fitzgerald et al. 1974; Bright & Marrs 
1982, 1983, 1986, 1987; Marrs & Bright 1986, 1987; Marrs 
et al. 1991; Baskin & Fricke 1992; Scharf et al. 1992; Brown 
et al. 1993; Menton et al. 1997). It may seem strange that a 
compound originally intended as an antidote is now being 
used as a vertebrate pesticide. However, in early experiments 
it was observed that PAPP was specifically much more toxic to 
carnivores than to other species (Plzak & Doull 1963; Savarie 
et al. 1983; Scawin et al. 1984) and this has been confirmed, 
with birds and humans being less sensitive (Fisher & O’Connor 
2007; Murphy et al. 2007).
The use of PAPP as a toxin for control of animal pests 
was first investigated in the 1980s by researchers in the U.S. 
Fish and Wildlife Service (Pan et al. 1983; Savarie et al. 1983; 
Schafer et al. 1983) as a tool for coyote (Canis latrans) control. 
In Australia, PAPP has been researched for its use for field 
control of feral cats, foxes (Vulpes vulpes) and wild dogs (Canis 
familiaris) (Marks et al. 2004; Fleming et al. 2006; Lapidge 
et al. 2007; Eason et al. 2010a). In New Zealand, PAPP has 
been studied in five species, namely ferrets (Mustela furo) 
(Fisher et al. 2007), dogs (Murphy et al. 2007), feral cats and 
stoats (Fisher et al. 2005; Eason et al. 2010a; Murphy et al. 
2011) and weasels (Mustela nivalis) (Blackie et al. 2012). The 
initial drive in terms of completion of field trials and registration 
prioritised and focused on feral cats and stoats in part because 
of their pest status, particularly in the case of stoats and in 
part because of the proven susceptibility of these species to 
PAPP (Dilks et al. 2011; Shapiro et al. 2010; Murphy et al. 
2011). The development of PAPP as part of the suite of tools 
for protecting native species in New Zealand, and its approval 
by the New Zealand EPA in 2011, was a big step forward. Its 
use should complement trapping and allow those involved in 
endangered species protection the ability to use a combination 
of tools. Most concerns in New Zealand regarding the use of 
poisons relate to fears about contamination of water supplies, 
possible sublethal effects on humans, welfare impacts, and 
non-target effects. In the following sections, the characteristics 
of PAPP are described relative to these concerns, including 
its mode of action and metabolism, acute toxicity in different 
species, its toxicokinetics and breakdown in the environment, 
sublethal effects, relative humaneness and other characteristics.
Mode of action
PAPP’s primary mode of action is via a toxic effect on 
red blood cells, mediated by a toxic metabolite, para-
hydroxylaminopropiophenone (PHAPP) (DeFeo et al. 1972). 
Following administration or ingestion in bait, PAPP is absorbed 
into the blood stream. PAPP is thought to undergo metabolic 
biotransformation to PHAPP. The basis for this is an analogy 
with the mechanism of methaemoglobinogenesis of analine 
and substituted anilines (Graffe et al. 1964; Kiese 1974). This 
toxic metabolite, although short acting, effectively oxidises 
haemoglobin to methaemoglobin (Graffe et al. 1964). This 
reaction can be rapid, peaking in 30 min or less (Goldstein 
& Doull 1973). Methaemoglobin is the oxidised form of 
haemoglobin, where the central iron is in the ferric (3+), 
rather than ferrous (2+) state. The ferric form of iron has a 
great affinity for cyanide, which it readily sequesters, and is 
the mode of PAPP’s antidotal action.
However, methaemoglobin is also unable effectively to 
transport oxygen. Therefore, while a partial conversion of 
haemoglobin to methaemoglobin (15–30%) may be beneficial 
in a situation of cyanide exposure, the oxidation of haemoglobin 
to methaemoglobin is lethal if high levels of conversion 
(>70%) are induced, resulting in a lack of oxygen to the brain 
and heart, and death due to respiratory failure (Coleman & 
Coleman 1996). Normally, methaemoglobin levels in the blood 
are <1%. Symptoms are proportional to the methaemoglobin 
concentration in the blood and include skin colour changes (blue 
or greyish pigmentation), blood colour changes, and lethargy, 
with severe methaemoglobinaemia being fatal. Methylene 
blue will reverse the methaemoglobinaemia induced by PAPP 
and is considered an antidote to PAPP exposure (Bodansky & 
Gutmann 1947; Coleman & Coleman 1996).
PAPP belongs to a class of chemicals broadly classified as 
aromatic amines. In most species, aromatic amines (R-NH2) 
are metabolised via acetylation of the amine moiety, prior to 
excretion. The N-acetyltransferases are cystolic enzymes found 
in all mammal species, with the exception of canids (Trepanier 
et al. 1997). N-acetyltransferases have been characterised in 
humans, rabbits, mice and hamsters (Mesocricetus auratus) 
(Vatsis & Weber 1997). By contrast, N-acetyltransferases 
activity is absent in the domestic dog (Canis lupus familiaris), 
red wolf (C. l. rufus), arctic wolf (C. l. arctos), coyote (Canis 
latrans), golden jackal (C. aureus), African wild dog (Lycaon 
pictus), arctic fox (Vulpes lagopus), kit fox (V. velox), and 
the silver fox (V. vulpes) (Trepanier et al. 1997). It is likely 
given their susceptibility that carnivores are also deficient in 
N-acetyltransferases.
Hydroxylation of PAPP to PHAPP has been demonstrated 
in vitro using rat, rabbit and human liver microsomes (Graffe 
et al. 1964; von Jagow et al. 1966; von Jagow & Kiese 1967; 
Coleman & Kuhns 1999) and in vivo in rats (Wood et al. 1991). 
The mode of action of PAPP was also studied by Wood et al. 
(1991) who examined the responses of rats, beagles (domestic 
dog) and cynomolgus monkeys (Macaca fascicularis) to 
PAPP administered orally. When PAPP was administered 
orally, methaemoglobin rapidly formed. However, when PAPP 
was administered directly into the blood, it did not induce 
methaemoglobin. On the basis of these results, it was considered 
that a hepatic biotransformation is responsible for converting 
PAPP to PHAPP and is the required pathway for activation of 
the compound. Biotransformation of PAPP by liver microsomes 
is now known to be dependent on several P-450 isoenzymes 
in the rat and in humans (Coleman & Kuhns 1999).
Figures detailing the mode of action for PAPP and 
the metabolic pathway for PAPP in different species are 
presented by Baskin and Fricke (1992) and Wood et al. 
(1991), respectively. Once conversion to PHAPP has occurred 
in the liver, it participates in a redox cycle in circulating 
erythrocytes. Methaemoglobinaemia is exacerbated in this 
process by intraerythrocytic NADPH (nicotinamide adenine 
dinucleotide phosphate) generated from glucose-6-phosphate 
dehydrogenase, which also reduces a secondary PAPP 
metabolite, p-nitrosopropiophenone (PNPP), back to the potent 
methaemoglobin inducer PHAPP (Baskin & Fricke 1992). 
These actions of PHAPP compete with the methaemoglobin 
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reductase system (Smith & Beutler 1966). Toxicity occurs 
when the oxidation process exceeds the rate of the reduction 
process, allowing high levels of methaemoglobin to be formed.
In contrast to the NADPH-dependent process, significant 
NADPH-reduction of methaemoglobin requires a co-factor 
or artificial electron carrier, such as methylene blue (Smith 
& Beutler 1966; Stolk & Smith 1966; Umbreit 2007). There 
are differences between species in the presence and relative 
activities of both of these systems. Rabbits and rodents appear 
to tolerate the pharmacological effect of PAPP quite well, 
owing to their relatively high NADPH-dependent capacity 
to convert methaemoglobin to haemoglobin. Conversely, cats 
and dogs are similarly more susceptible because of their lower 
NADPH-dependent capacity (Smith & Beutler 1966; Stolk 
& Smith 1966; Agar & Harley 1972; Rockwood et al. 2003). 
NADPH-dependent capacity in beagles is approximately two-
thirds that of humans (Rockwood et al. 2003).
While examining species differences in methaemoglobin 
reductase systems, the human NADPH system was shown 
to possess the greatest capacity to up-regulate reduction of 
methaemoglobin in the presence of methylene blue (Smith 
& Beutler 1966). The degree to which methaemoglobin is 
reduced to haemoglobin in the presence of the antidote was 
6-fold greater than in its absence, and exceeded that of other 
species tested. This is highly relevant in the context of assessing 
the risk PAPP presents to human health when used in baits as 
a vertebrate pesticide.
Early investigators into the effects of PAPP noted that 
lethal doses were far lower in some species (e.g. dogs and 
cats) than in others (Savarie et al. 1983; Sharf et al. 1992) 
for the reasons cited above. Methaemoglobinaemia can be 
induced in all species but reaches lethal concentrations most 
readily in carnivores (e.g. cats, dogs, foxes). This is consistent 
with the rapid onset of symptoms observed in cats, foxes and 
stoats, which usually become unconscious within 30–45 min 
(Marks et al. 2004; Eason et al. 2010b) following toxic doses. 
Gender differences in PAPP toxicity have also been reported, 
with female mice less susceptible and female rats and beagles 
more susceptible (Doull & Plzak 1963; Bright et al. 1987).
Acute toxicity
An extensive database on the acute toxicity of PAPP in a diverse 
spectrum of species exists. As with other poisons, reported 
LD50 values can be influenced by the method used to deliver 
the poison, and by environmental or laboratory conditions and 
protocols. Oral gavage of PAPP in several different carrier 
materials has been a standard dosing approach used by many 
researchers (Plzak & Doull 1963; Savarie et al. 1983; Scawin 
et al. 1984). Alternatively, PAPP has been fed to animals 
in measured quantities of foodstuffs or in prepared baits. 
Nevertheless, it is still relatively easy to see the substantial 
species variation that has been reported in the literature over 
the years. Table 1 shows acute oral toxicity LD50 values for 
a number of mammalian species. LD50 of PAPP in the two 
target pest species in New Zealand, namely stoats and feral 
cats, is <10 mg kg–1. Cats and stoats are extremely susceptible, 
and as noted above, most other mammalian carnivores are 
highly sensitive to poisoning, with lethal doses that are far 
lower in these species than non-carnivorous mammalian 
species (Tables 1 & 2). There is no LD50 value for humans. 
Table 1. Oral LD50 values available for PAPP on a range of mammal species. a Calculated 80% increase in methaemoglobin 
concentration, which correlated strongly with LD50 values (NWR 2006).__________________________________________________________________________________________________________________________________________________________________
Animal LD50 mg kg–1 Reference__________________________________________________________________________________________________________________________________________________________________
Cat (Felis catus) 5.6 Savarie et al. 1983
Coyote (Canis latrans) 5.6 Savarie et al. 1983
Brown bandicoot (Isodon obesulus) 6.4 a NWR 2006
Dingo (Canis familiaris dingo hybrid) 8.5 a NWR 2006
Stoat (Mustela erminea) 9.3 Fisher et al. 2005
Bobcat (Lynx rufus) 10 Savarie et al. 1983
Kit fox (Vulpes velox) 14.1 Savarie et al. 1983
Ferret (Mustela furo) 15.5 Fisher & O’Connor 2007
Spotted-tail quoll (Dasyurus maculatus) 24.8 a NWR 2006
Red fox (Vulpes vulpes) <25.2 Marks et al. 2004
Dog (Canis familiaris) < 50 Vandenbelt et al. 1944
Dama wallaby (Macropus eugenii) 89 Fisher et al. 2008
Badger (Taxidea taxus) c. 100 Savarie et al. 1983
Fat-tailed dunnart (Sminthopsis crassicaudata) 105 a NWR 2006
Tasmanian devil (Sarcophilus harrisii) 120 a NWR 2006
Raccoon (Procyon lotor) 142 Savarie et al. 1983
Stripped skunk (Mephitis mephitis) >400 Savarie et al. 1983
Rat (Rattus norvegicus – male) 177 Savarie et al. 1983
Rat (Sprague-Dawley) 221 Pan et al. 1983
Rat (Rattus sp. – female) 224 Scawin et al. 1984
Rat (Rattus sp. – Porton-Wistar male) 475 Scawin et al. 1984
Mouse (Mus musculus – Swiss Webstar) 168 Pan et al. 1983
Mouse (Mus musculus – albino male) 233 Savarie et al. 1983
Mouse (Mus musculus – Porton albino female) > 5000 Scawin et al. 1984
Brown antechinus (Antechinus stuartii) >571 a NWR 2006
Bush rat (Rattus fuscipes) 697 a NWR 2006
Brushtail possum (Trichosurus vulpecula) ≥500 Fisher et al. 2008
Guinea pig (Cavia porcellus – Dunkin Hartley) 1020 Scawin et al. 1984
__________________________________________________________________________________________________________________________________________________________________
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However, cynomolgus monkeys have been administered 150 
mg kg–1 day–1 for 2 weeks without mortality (Lackenby 1987a), 
hence the single-dose oral LD50 for this species is clearly well 
in excess of 150 mg kg–1, and it is probable that this is also 
the case for humans.
PAPP has been shown to be generally less toxic to birds 
than to mammalian carnivores (Table 2). In some investigations, 
the birds were administered PAPP directly to the stomach by 
oral gavage (Savarie et al. 1983; Schafer et al. 1982; Fisher 
et al. 2008). Further data have been generated in New Zealand 
to assess the toxicity to birds of the formulated PAPP paste 
presented in a meat bait (Eason et al. 2010c), as this is how 
PAPP is currently used for the control of both stoats and feral 
cats (Shapiro et al. 2010; Dilks et al. 2011; Murphy et al. 
2011). Four bird species were assessed as representative 
non-target species. Forty Australian magpies (Gymnorhina 
tibicen), 20 blackbirds (Turdus merula), 20 mallard ducks 
(Anas platyrhynchos) and 21 weka (Gallirallus australis) were 
dosed orally with PAPP in the form of a 40% paste. The PAPP 
paste was added to meat as a delivery vehicle. The lethal dose 
to kill 50% (LD50) of magpies was 1387 mg kg–1, 174 mg kg–1 
for blackbirds and 32 mg kg–1 for mallard ducks (Eason et al. 
2010c). An LD50 of 568 mg kg–1 was determined for weka; 
however, this LD50 value underestimates the risk to weka as 
they were significantly affected at the lowest dose tested (62 
mg kg–1) (Eason et al. 2010c). Weka became subdued and lost 
their appetite until they were euthanased 30 h after dosing.
Eason et al. (2010c) confirmed that while ducks are 
more susceptible to PAPP than other birds, they are still 
less susceptible than stoats or cats and there is considerable 
interspecies variation in response to PAPP by birds. While 
birds are less susceptible to PAPP than stoats or feral cats, or 
mammalian carnivores in general, it appears some bird species 
are adversely affected and it will be important to limit their 
exposure when PAPP is used for predator control. The risk to 
any non-targets will be less with stoat bait than a cat bait, as 
only c. 13 mg PAPP is needed for stoats compared with c. 80 
mg PAPP for cats (Murphy et al. 2007; Shapiro et al. 2010).
As a result of our understanding of PAPP’s mode of action, 
variations in LD50 values can be viewed as a function of the 
differences in the metabolism of PAPP between species, in 
the metabolism and excretion of the degradation products 
(Wood et al. 1991), differences between species in the rates 
of haemoglobin oxidation (Smith & Beutler 1966), and to 
a lesser extent, in the relative capacity of species to reduce 
methaemoglobin to haemoglobin.
Of a range of iconic Australian native mammals assessed 
for the effects of orally administered PAPP, only the southern 
brown bandicoot (Isoodon obesulus) and spotted-tail quoll 
(Dasyurus maculatus) were more sensitive than dogs (NWR 
2006; McLeod & Saunders 2013) (see Table 1). Of the 
two reptile species (Varanus sp.) assessed, only the goanna 
(V. rosenbergis) was more sensitive than dogs (NWR 2006; 
McLeod & Saunders 2013). This sensitivity of reptiles, 
as shown in Table 2, could have relevance to PAPP use in 
New Zealand and care with baiting strategies will be advisable. 
In a practical sense, the risk from the use of PAPP needs to be 
evaluated in the context of the impacts of stoats and feral cats 
on threatened species populations including reptiles.
With regard to fish species, QSAR analysis has been 
carried out to predict LC50 values for guppies (Poecilia 
reticulata), with reported values ranging from 23 to 623 
mg L–1 (Karabunarliev et al. 1996). For fathead minnows 
(Pimephales promelas), predicted LC50 values ranged from 
52 to 201 mg L–1 (Karabunarliev et al. 1996; Kulkarni et al. 
2001). However, this research is of limited relevance to PAPP 
use as a predacide in New Zealand but is reported here for 
completeness.
Toxicokinetics and exposure risks
Wood et al. (1991) investigated the metabolism and excretion 
of radio-labelled PAPP in Sprague-Dawley laboratory rats 
(Rattus norvegicus), dogs and cynomolgus monkeys. PAPP 
was rapidly absorbed by all three species, with peak plasma 
Table 2. PAPP oral LD50 values for bird and reptile species. a Calculated 80% increase in methaemoglobin concentration, 
which correlated strongly with LD50 values (NWR 2006).__________________________________________________________________________________________________________________________________________________________________
 LD50 (mg kg–1) Reference__________________________________________________________________________________________________________________________________________________________________
Avian species  
Mallard duck (Anas platyrhynchos Pekin breed) 32 Eason et al. 2010c
Mallard duck (Anas platyrhynchos Pekin breed) 38 Fisher et al. 2008
Little Australian raven (Corvus coronoides) 130 a NWR 2006
Red-winged blackbird (Agelaius phoenicus) 133 Savarie et al. 1983
Eurasian blackbird (Turdus merula) 174 Eason et al 2010c.
Common crow (Corvus brachyrhynchos)  178 Savarie et al. 1983
Black-billed magpie (Pica pica) 178 Savarie et al. 1983
Coturnix quail (Coturnix coturnix) > 316 Savarie et al. 1983
Starling (Sturnus vulgaris) > 316 Savarie et al. 1983
Weka (Gallirallus australis) 568* Eason et al. 2010c
Silver gull (Larus novaehollandiae) >1000 a NWR 2006
Australian magpie (Gymnorhina tibicen) 1387  Eason et al. 2010c
Golden eagle (Aquila chrysaetos) 1/1 survived at 50, 100,  Savarie et al. 1983 
 200, 400 mg kg–1 
Reptile species  
Lace monitor (Varanus varius) 3 Frapell 2007 (cited in McLeod & Saunders 2013)
Rosenberg’s goanna (Varanus rosenbergi) 12 Frappell & Andrewartha 2006 (cited in McLeod &  
  Saunders 2013)
__________________________________________________________________________________________________________________________________________________________________
*While weka did not die at lower doses, they became subdued and lost their appetite at a PAPP concentration of 50 mg kg–1.
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concentrations at 15 min (male rats), 1 h (female rats), 30 min 
to 1 h (beagles) and 1 to 1.5 h (monkeys) after oral ingestion. 
As a result of metabolic and excretory processes (Wood et al. 
1991), levels of plasma radioactivity decline rapidly, with 
plasma concentrations declining to very low levels by 72 h.
As described above (see Mode of Action) there are marked 
differences in the metabolic pathways in different species. In 
rats, PAPP was metabolised primarily by N-acetylation, in dogs, 
aliphatic hydroxylation predominated, whereas monkeys used 
both of these metabolic pathways. The increased capacity of 
primates to metabolise PAPP to non-toxic compounds when 
compared with canids is one reason why humans are at reduced 
risk of acute PAPP toxicosis.
The principal route of excretion of PAPP is via the kidneys 
in urine (between 65% and 90% of a dose), with excretion via 
faeces and in expired air contributing minimally (Tepperman 
et al 1946; von Jagow et al. 1966; von Jagow & Kiese 1967; 
Wood et al. 1991). Some PAPP metabolites were present in the 
bile of dogs and rats (Wood et al. 1991), but these appear to 
be reabsorbed via the intestine by enterohepatic recirculation 
and ultimately also excreted in the urine, as also happens in 
rabbits (von Jagow et al. 1966; von Jagow & Kiese 1967; Wood 
et al. 1991). Owing to the different metabolic pathways for 
PAPP between species, the forms of PAPP metabolites differ 
significantly (Tepperman et al 1946; von Jagow et al. 1966; 
von Jagow & Kiese 1967; Wood et al. 1991).
Wood et al. (1991) observed rapid excretion of PAPP via 
urine and faeces in rats, beagles and cynomolgus monkeys given 
oral doses of 0.5, 5, and 25 mg kg–1 PAPP, respectively. All 
animals were monitored for 120 h after PAPP administration. 
The majority of PAPP and its metabolites were excreted in 
urine and faeces within 24 h (93–96% in rats, 84% in dogs, and 
84–95% in monkeys). Further details of the pharmacokinetics, 
including figures of plasma versus time concentration profiles 
and metabolic pathways, for these species can be found in 
Wood et al. (1991).
An elimination half-life for PAPP in plasma for rats has 
not been published. Phenones, compounds that are chemically 
related to PAPP, have relatively short half-lives in the blood 
(Paulet et al. 1963; Marino et al. 1997). For the purposes of 
this review, and to enable comparison with other vertebrate 
pesticides, the half-life for PAPP has been estimated using data 
on the concentration of radioactivity in plasma of Sprague-
Dawley rats after oral gavage with 14C PAPP over a period of 
96 h, extracted from fig. 1 in Wood et al. (1991). A standard 
simple pharmacokinetic model was fitted and the elimination 
half-life was estimated to be c. 4 h (Elena Moltchanova, 
University of Canterbury, Christchurch, unpubl. data). By 
comparison, the active hydroxylated metabolite PHAPP has 
an exceedingly short half-life of c. 1 min (Wood et al. 1991). 
While no studies were found where depletion of PAPP was 
monitored to the point where it could no longer be detected, 
information on the pharmacokinetics of PAPP in rats, dogs 
and monkeys (Wood et al, 1991) is very comprehensive and it 
would appear that PAPP is likely to be completely eliminated 
in mammals in about 5 days.
By comparison, there is a huge variation in the way that 
different VTAs are absorbed, distributed, metabolised and 
excreted by mammals (Eason et al. 2008, 2011, 2012; Crowell 
et al. 2013). At one end of the spectrum there are compounds 
that are very water soluble, rapidly absorbed, well distributed 
and equally rapidly excreted, such as 1080 and cyanide. There 
are others that are extensively metabolised to more hydrophilic 
metabolites, such as cholecalciferol and diphacinone, and yet 
others that are lipophilic and poorly metabolised and exhibit 
unique receptor-binding characteristics, such as second-
generation anticoagulants. The rapid metabolism and clearance 
of PHAPP and PAPP is a great advantage in the context of 
the application of PAPP as a prospective predacide because 
the risks of bioaccumulation in the food chain or secondary 
poisoning are significantly reduced.
The toxicokinetic information summarised above indicates 
that PAPP is likely to be slightly more persistent than cyanide in 
live animals but as, or less persistent than 1080, and substantially 
less persistent than anticoagulants. In conclusion, all species 
studied to date rapidly metabolise and excrete sublethal doses 
of PAPP. If recommended practices are followed in pest control 
operations, PAPP is unlikely to be present in game-meat, sheep 
or cattle for human consumption because of its comparatively 
rapid elimination. This means it will not bioaccumulate in the 
food chain, and secondary poisoning risks are low, particularly 
for the majority of bird species.
Toxicodynamics, welfare and antidote 
treatment
One of the key drivers for developing PAPP has been animal 
welfare. When delivered at a lethal dose, rapid induction of high 
levels of methaemoglobin can quickly induce unconsciousness 
and death with minimal symptoms of distress (Eason et al. 
2010b). Rapidly induced anoxia is the cause of death and 
appears to be without appreciable pain or discomfort in 
much the same way as anoxia induced by carbon monoxide 
induces carboxaemia. Symptoms are proportional to the 
methaemoglobin concentration in the blood (Smith 1967, 
1969; Rentsch 1968; Goldstein & Doull 1973).
In most species, peak methaemoglobin concentrations 
follow peak plasma PAPP levels by approximately 30–60 
min (Paulet et al. 1963; Bright & Marrs 1982, 1983; Marino 
et al. 1997). This lag is a function of at least three processes 
— first, PAPP absorption; second, PAPP metabolism to an 
active metabolite; and third, the accumulation of PHAPP in 
red blood cells to a minimum effective concentration (Marino 
et al. 1997). The duration of the lag phase and the severity 
of symptoms will be dose dependent. During the lag phase, 
varying amounts of PHAPP will have oxidised a proportion of 
haemoglobin to methaemoglobin. Counteracting this, PHAPP 
and PAPP are metabolised to inactive derivatives prior to being 
cleared via the kidneys. Therefore, by the end of the first two 
hours, methaemoglobinaemia either will have reached peak 
(or lethal) concentrations, or have begun to decline because 
of enzymatic reduction of methaemoglobin to haemoglobin 
by methaemoglobin reductase, in which case the animal will 
recover. However, these outcomes and the duration of these 
processes and effects are dose, dosing vehicle, and species 
dependent.
Detailed observations in pen trials using 20 feral cats and 
15 stoats were undertaken using meat baits containing toxic 
doses of PAPP (Eason et al. 2010b). Of the 20 cats, 18 died after 
eating PAPP bait while two survived. The cats showed a range 
of responses, with the onset of symptoms occurring between 35 
and 112 min and death between 37 and 246 min. One animal 
that ate only a fraction of the dose of PAPP recovered. Cats 
exposed to lethal doses of PAPP lost consciousness without 
spasms or convulsions. All 15 stoats died quickly after eating 
the PAPP bait. The stoats showed first symptoms 6–40 min 
after ingestion and death between 15 and 85 min. There were 
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minimal signs of discomfort with poisoning; animals became 
quiet, lethargic, and then unconscious for a short period before 
death. There was no prolonged period of heavy breathing. 
These results confirmed the findings of earlier New Zealand 
studies in these two species (Fisher et al. 2005).
Although both cyanide and PAPP cause central nervous 
system anoxia, lethargy and death, it occurs through different 
mechanisms of toxicity. The sequence of events observed in 
both cyanide and PAPP poisoning are preferable, from a welfare 
perspective, to those seen with other poisons. In the simplified 
ranking system outlined in Table 3, cyanide is scored as a ‘high’ 
performing poison from a welfare perspective. Applying the 
same parameters to the effects of lethal doses of PAPP in feral 
cats and stoats, we would also consider PAPP to be a ‘high’ 
performer from a welfare perspective. The lethal response of 
feral cats and stoats to PAPP was rapid and appeared relatively 
free of the suffering that accompanies the use of some other 
toxins (Littin et al. 2002; Goh et al. 2005; Potter et al. 2006). 
The key parameters of note in welfare assessment of a VTA 
are the time to onset of symptoms, the duration of symptoms, 
and the severity of symptoms induced by toxic doses in target 
species, particularly up to the point where unconsciousness 
and insensibility occur. When these symptoms and times are 
compared with other VTAs (Table 3), it appears that PAPP is 
comparatively humane. Even in species such as rats where the 
sequence of PAPP-induced toxicosis is more prolonged when 
compared with stoats or feral cats, the severity of symptoms 
associated with PAPP-induced methaemoglobinaemia was 
determined to be relatively humane when compared with other 
rodenticides (Gibson et al. 2011).
Less susceptible animals that are accidentally exposed 
to PAPP suffer only partial methaemoglobinaemia that is 
transitory and causes no clinical symptoms (Gibson et al. 2011). 
Its effects can be reversed, even in late stages of toxicosis, by 
the administration of methylene blue, which is an antidote. 
Animals treated promptly and effectively with the antidote 
can fully recover, even from near-terminal late-stage toxicosis 
induced by PAPP. Such an antidote is not available for existing 
canid control agents such as 1080, which is considered less 
humane than PAPP for canid control in Australia (Southwell 
et al. 2011, 2013). The availability of an antidote is also 
considered advantageous where there is a risk of exposure of 
working dogs to bait.
The effectiveness of methylene blue as an antidote 
to PAPP-induced methaemoglobinaemia was assessed 
in dogs by Bodansky and Gutmann (1947) and Stossel 
and Jennings (1966), who showed that it was highly and 
rapidly effective in counteracting the symptoms of severe 
methaemoglobinaemia. Moreover, a majority of dogs that 
received the life-saving treatment recovered fully within hours 
and appeared physiologically normal days after the methylene 
blue intervention (Bodansky & Gutmann 1947). In addition, 
healthy dogs (anesthetised) who were given methylene blue 
intravenously, at doses exceeding 30 mg kg–1, responded only 
with a rise in total circulating haemoglobin but were otherwise 
unaffected (Stossel & Jennings 1966).
The effectiveness of the antidote and its relatively wide 
therapeutic window make it the clinical treatment of choice. 
It remains the current best practice for the treatment of all 
methaemoglobinaemias. The treatment indication involves 
intravenous administration of methylene blue at 1–2 mg kg–1 of 
body weight formulated as an aqueous solution and administered 
over a 5-min period (WHO & CEC 1993; Greenberg 2001; 
Boylston & Beer 2002). Doses of methylene blue should not 
exceed 7 mg kg–1. This is also the dose range that is used in 
veterinary medicine in the treatment of methaemoglobinaemia 
(Bodansky & Gutmann 1947). Treatment with the antidote 
is contraindicated at methaemoglobin concentrations below 
approximately 30%, which generally do not result in clinical 
symptoms and resolve themselves naturally once the causative 
agent is removed. Doses may be administered intravenously 
or orally following dilution of a stock solution.
Table 3. Summary of average times until onset of clinical signs of toxicosis, duration of key symptoms during sickness 
behaviour, and time to death in possums (Trichosurus vulpecula) following ingestion of poison baits (adapted from Eason 
et al. (2010a), with data included for PAPP).
__________________________________________________________________________________________________________________________________________________________________
Toxin Average time until  Sickness behaviour Average Average time Reference 
 onset of sickness  duration until death 
__________________________________________________________________________________________________________________________________________________________________
Cyanide 3 min Ataxia, impaired  15 min 18 min Gregory et al. 1998 
  coordination, breathlessness,  
  muscular spasms.  
  Unconscious after 6.5 min 
PAPP <45 min Lethargy 30–60 min 40–80 min Eason et al. 2010b
Zn3P2 1.5 h Vomiting, epigastric pain, 2.4 h 4.0 h Eason et al. 2012 
  ataxia, breathlessness 
1080 Approx. 2 h Anorexia, ataxia,  9 h 5 h Littin et al. 2009 
  occasional retching, spasms,  
  breathlessness, laboured 
  breathing 
Phosphorus paste 6 h Retching, vomiting,  19 h 25 h O’Connor et al. 2007 
  hunched posture,  
  intermittent repositioning,  
  ataxia 
Brodifacoum 14 days Reduced feeding, ataxia,  7 days 21 days Littin et al. 2002 
  haemorrhages, prolonged  
  lying down
__________________________________________________________________________________________________________________________________________________________________
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Sublethal effects and exposure risk in humans 
and animals
Risk assessment is improved when fundamental research 
provides information about the fate, effects, and risk of exposure 
to PAPP. Hence, pharmacokinetics and the mechanism of 
toxicity are important in understanding the response of an 
animal or humans to a foreign compound. PAPP clearly has 
the potential to kill and cause transient sublethal effects in 
humans, but exposure of individuals or communities to amounts 
of PAPP that would cause such effects is most unlikely when 
it is used carefully for predator control. The acute toxicity 
of PAPP is well understood, and the toxic manifestations of 
sublethal methaemoglobinaemia have been extensively studied 
as described above (see Mode of Action). These are further 
explored below. As noted above, methaemoglobinaemia results 
in tissue anoxia, leading to respiratory failure and death when 
sufficiently high doses are ingested. In the following sections, 
we cite publications that show that any sublethal toxicological 
effects associated with chronic exposure to PAPP are also likely 
to be linked to induction of methaemoglobinaemia.
Multi-dose studies in animals have been conducted 
to shed light on additional potential sublethal effects and 
possible target organ toxicity, using periods of exposure of 
14 and up to 30 days’ duration (Doull & Plzak 1963; Baskin 
& Fricke 1992: Blickenstaff et al. 1994). While most studies 
have focused on the effect of PAPP on red blood cell function, 
other effects have been recorded. In a review paper, Baskin 
and Fricke (1992) report results from earlier unpublished trials 
(Lackenby 1987a, b) on the sub-acute oral toxicity of PAPP in 
laboratory rats and cynomolgus monkeys exposed to a 14-day 
treatment period, followed by a 14-day treatment-free period. 
In both studies, standard haematology, clinical chemistry, urine 
analysis, and pathology were evaluated. The rat study consisted 
of four treatment groups, which were dosed daily with 0, 35, 
90 or 140 mg kg–1 for males and 0, 20, 50 or 130 mg kg–1 for 
females (Lackenby 1987b). Minor histopathological changes 
observed in PAPP-treated rats returned to control levels 
following cessation of treatment. In the cynomolgus monkeys 
(both sexes) dosed daily with 17, 50 or 150 mg kg–1 of PAPP, 
serum chemistry parameters, including lactate dehydrogenase 
(LDH) levels, increased (Lackenby 1987a). These changes are 
consistent with an effect on the liver. After treatments ceased, 
the abnormal serum chemistry values returned to control levels 
within 28 days. Baskin and Fricke’s (1992) review concludes 
that the pathological and histopathological effects seen with 
PAPP treatment were to be expected as consequences of high 
methaemoglobin concentrations, implying an indirect rather 
than a direct effect of PAPP on the liver. The study on PAPP 
in this primate species is particularly important with regard to 
risk assessment for humans and it is notable that the doses of 
150 mg kg–1 day–1 PAPP given to monkeys for 14 days were 
an order of magnitude greater than the single-dose LD50 in 
susceptible species such as stoats.
PAPP toxicology has also been studied in humans. 
Sublethal doses of PAPP administered did not adversely 
affect perception, as measured by visual rod-cell threshold 
in a dark setting at sea level or high altitudes post-exercise 
(Bodansky & Hendley 1946). Administration of low doses of 
PAPP did not decrease the oxygenation of working muscle in 
men exercising lightly (bicycle ergometer) with PAPP-induced 
methaemoglobin concentrations of between 7.5% and 15%. 
However, as the level of methaemoglobin progressed to 
concentrations above 20%, higher blood lactate levels were 
recorded in the subjects, with methaemoglobin levels of 21.7% 
and 27.1% but only at high workloads (Tepperman et al 1946).
Paulet et al. (1963) showed that sublethal doses (80 
mg or 100 mg) administered orally to 51 human volunteers 
produced methaemoglobin concentrations ranging from 2% 
to 48%. Peak methaemoglobin concentrations were typically 
reached 1–2 h post-ingestion and produced few if any side 
effects. There was no evidence of physical, intellectual or 
psychological impairment, appetite was not suppressed, and 
renal systems were normal. Furthermore, ventilation rate, 
arterial pressure, and electrocardiograms were unchanged pre- 
and post-ingestion, during the expected period of toxicosis in 20 
subjects and only slightly altered in two subjects. Haemolysis 
was not observed even at relatively high methaemoglobin 
concentrations of 48%. LD50 data are not available for humans 
but, in sublethal studies, oral doses of up to 10 mg kg–1 have 
been administered with few, if any, side effects other than 
methaemoglobinaemia. Therefore, the available data appear 
to indicate that PAPP is less acutely toxic to humans than to 
canids.
The carcinogenic potential of PAPP has been evaluated by 
in vitro and in vivo testing (Table 4). PAPP is not mutagenic 
and is unlikely to cause cancer, in part because of its lack of 
mutagenicity and in part because its use for vertebrate pest 
control should not involve significant exposure or absorption of 
the compound by non-target species including humans. PAPP 
tested as non-mutagenic in the Ames test, mouse micronucleus 
test, and the human lymphocyte test. In the forward gene 
mutation mouse lymphoma test, results were ambiguous, 
implying possible weak mutagenic activity. However, in 
studies to clarify the genotoxicity and mutagenicity of PAPP, 
it was shown not to be mutagenic (Table 4).
PAPP clearly has the potential to kill and cause transient 
sublethal effects in humans and, arguably, additional toxicology 
studies could provide more information for risk assessment. 
Equally, or probably more importantly, in a practical sense the 
use of PAPP must continue to include safeguards that focus on 
those individuals handling PAPP and operational safeguards to 
Table 4. Summary of genotoxicity tests for PAPP.
__________________________________________________________________________________________________________________________________________________________________
Test system Result  Reference
__________________________________________________________________________________________________________________________________________________________________
Mouse micronucleus No increase in micronuclei. Not mutagenic Asquith 1988a,b
Metaphase analyses in human lymphocytes No clastogenicity. Not mutagenic Cordery 1988a,b
Forward gene mutation in mouse lymphoma Weak indication of mutagenicity Thompson 1988
Ames test Not mutagenic Baskin & Fricke 1992
Unscheduled DNA synthesis in rat No evidence of unscheduled DNA synthesis.  Baskin & Fricke 1992 
 Not mutagenic
__________________________________________________________________________________________________________________________________________________________________
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prevent exposure of people to PAPP. Exposure of individuals 
or communities to amounts of PAPP that would cause effects 
should be most unlikely when it is handled and used carefully 
for predator control.
Fate in the environment
PAPP appears to have similar biodegradability and solubility 
as cyanide and 1080. PAPP is water soluble, so if any bait is 
displaced from a bait station the PAPP will be easily leached 
into the soil by rain. PAPP is mobile in soil and is reported to 
be biodegradable by microorganisms (Southwell et al. 2011) 
though further details are not provided. This information needs 
to be viewed in the context of how PAPP will be used. Because 
stoat numbers are low relative to other pests such as rats or 
possums, very few baits are used, hence limited environmental 
contamination will occur and contamination of waterways is 
unlikely. McLeod and Saunders (2013) report low toxicity to 
soil invertebrates.
With correct use of bait stations, the risk of contamination 
is considered very low, and would most likely only occur from 
deliberate or accidental spills directly into water. For example, 
in a recent trial, 90 baits were placed out, one per station, at one 
time over an area of c. 800 ha. Each bait contained c. 0.04 g of 
PAPP in meatball-type bait (Dilks et al. 2011). In total, there 
were no more than 4 g of PAPP in the field at one time, thus 
soil or water contamination would have been limited.
Methods of PAPP application
There has been a sustained effort to improve predator control 
and increase native species protection in New Zealand, as 
well as to improve target specificity and reduce non-target 
mortality. The development of PAPP for predator control has 
been consistent with this trend. The currently registered product 
containing PAPP is a soft, green paste that contains 410 mg 
kg–1 PAPP as the active ingredient. It comes in pre-loaded 
syringes packed in a secure carry-box with instructions. Baits 
are prepared by enclosing a small amount of paste in green-dyed 
raw minced-meat to form a small meatball. These meatballs 
are placed in bait stations. Meat baits containing PAPP must 
be treated as potentially poisonous to non-target species and 
must be handled as carefully as any other type of toxic bait. 
To date, field experience with PAPP is limited, but where it 
has been used it has been very successful. Trials undertaken 
in Waitutu Forest, Southland, achieved a reduction in stoat 
abundance of 83– 87% over five nights. These results indicate 
that PAPP is an effective toxin for stoats in the field and has 
the potential to provide a significant new tool for conservation 
of native species (Dilks et al. 2011). Similar results have been 
obtained with radio-collared feral cats (Shapiro et al. 2010; 
Murphy et al. 2011). Long-life baits are being researched 
and a resetting toxin delivery system to achieve long-term 
suppression of stoat populations have been shown to be 
effective in pen trials (Blackie et al. 2012). Stoats have been 
killed in enclosure trials by a paste containing PAPP sprayed 
onto the chest and stomach by a resetting systems triggered 
by the stoats passing through a tunnel (Blackie et al. 2012), 
and the first field trials to successfully demonstrate that PAPP 
delivered in a resetting device could reduce stoat abundance 
were completed in 2013 (Ministry of Business, Innovation 
and Employment in collaboration with Connovation Ltd and 
the Department of Conservation).
Conclusions
PAPP is the first toxin registered for stoat control in 
New Zealand and the first new toxin registered for mammalian 
pest control anywhere in the world for at least 20 years. The 
approval of PAPP paste as a stoat and feral cat control agent 
in New Zealand was achieved through collaboration between 
Connovation, Lincoln University, and the Department of 
Conservation. The development of PAPP for predator control 
in New Zealand also owes a lot to earlier work by researchers 
investigating the mode of action and toxicological properties 
of PAPP, as well as its potential for animal pest control. 
The availability of PAPP as a new toxin reinforces the 
concept of the pest control toolbox, where a variety of methods 
are available for use to protect threatened bird species. With 
the sustained trapping of stoats over many years in some areas, 
there is growing concern that trap shyness is developing: having 
another option such as the use of PAPP will strengthen the 
ability of pest control agencies and conservationists to better 
control stoats and feral cats, although selection of the most 
appropriate tool depends on factors such as site location and 
ease of access.
In this review, we have reported research spanning 60 years 
and have focused on several factors, including determining 
the toxicity of PAPP to predators, its field effectiveness for 
controlling stoats and feral cats, its animal welfare profile, 
toxicology, ecotoxicology, and understanding its non-target 
risk. It has been developed specifically for the control of 
stoats and feral cats because of the special sensitivity of these 
species to PAPP. Its toxicity is mediated by the induction 
of methaemoglobinaemia. The benefits of PAPP use in 
conservation and pest control should be weighed up alongside 
the risks of using PAPP and alternative techniques for pest 
control. Even though there are advantages for PAPP over other 
toxins, considerable care must be taken when using PAPP to 
ensure that the risks of its use are outweighed by the ecological 
benefits achieved. The advantages and disadvantages of PAPP 
are summarised simply below.
Advantages Disadvantages
____________________________________________________________________________
Simple antidote  Not broad spectrum
Humane (very rapid action) 
Low environmental impact  
and secondary-poisoning risk
However, there has been limited practical experience with 
PAPP to date, especially when compared with alternative 
tools such as traps for pest control or baits containing 1080. 
The conditions of use imposed by the EPA and the Ministry 
for Primary Industries (MPI) have restricted the use of PAPP 
for native species protection so far, in 2013. A review of these 
conditions has been initiated with both agencies. Innovation 
needs to be stimulated to encourage improvement in endangered 
species protection. Unfortunately, regulatory impediments are 
currently restricting PAPP use to licensed operators. Ideally, 
researchers need to work closely with regulators, to ensure 
that vertebrate pest product registrations and regulations on 
the use of new tools enable conservation. Additional research 
efforts and practical experience, coupled with more appropriate 
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regulation on its use, should enable the effective use of PAPP 
as a tool to help achieve better conservation outcomes within 
New Zealand. At the time of writing, PAPP can only be used in 
fresh meat baits, but long-life baits and resetting toxin delivery 
systems should enable PAPP to be used more effectively for 
the long-term suppression of predators.
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